beta
/Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised, double-blind, phase 2 trial
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)